NIH-funded research R01 grant

Understanding how glucose transport is regulated in metabolic syndrome

Official title: Vesicle Translocation and the Metabolic Syndrome

Funded at Yale University · NIH-11039963 · Data updated 2026-11-12

This study looks at how insulin helps your body use sugar by focusing on a special protein that helps move sugar transporters to where they’re needed in your cells, and it aims to find out what goes wrong in people with insulin resistance, which could lead to better treatments for type 2 diabetes.

More Metabolic Syndrome research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startApril 1, 2022
Project endFebruary 28, 2026
Funding year2025
Award (this year)$516,235
NIH project number5R01DK129466-04
Project IDNIH-11039963 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with insulin resistance, metabolic syndrome, or type 2 diabetes.

Less likely to help

Patients without metabolic disorders or those who do not have issues with glucose regulation may not benefit from this research.

What this research studies

This research investigates the mechanisms by which insulin regulates glucose uptake in muscle and fat cells, focusing on the role of a protein called TUG in the trafficking of GLUT4 glucose transporters. By examining how insulin triggers the movement of these transporters to the cell surface, the study aims to uncover the disruptions that lead to insulin resistance and metabolic syndrome. Patients may benefit from insights into how their bodies manage glucose, which could inform new treatment strategies for conditions like type 2 diabetes.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for managing blood sugar levels in patients with metabolic syndrome and type 2 diabetes.

How similar studies have gone: Previous research has shown promising results in understanding glucose transport mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Bogan, Jonathan — Yale University
  • Study coordinator: Bogan, Jonathan

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.